scotPHO introduction:
  Allergic conditions
  Asthma
  Cancer
  Overview
  Breast Cancer
  Colorectal Cancer
  Lung Cancer
  Prostate Cancer
  Key points
  Introduction
  Risk factors
  Policy context
  Data
  Key data sources
Key references and evidence
  Useful links
  CHD
  Chronic Liver Disease
  Chronic Obstructive Pulmonary Disease (COPD)
  Diabetes
  Disability
  Epilepsy
  Hepatitis C
  Immunisations
  Infections
  Injuries
  Mental Health
  Multiple Sclerosis
  Oral Health
  Stroke
  Suicide
Text Only  |  Text Size: A |  A+ |  A++

Prostate cancer: key references and evidence

References

Black R, Stockton D (eds). Cancer scenarios: An aid to planning cancer services in Scotland in the next decade. Edinburgh: Scottish Executive, 2001.

Brewster DH, Fraser LA, Harris V, Black RJ.  Rising incidence of prostate cancer in Scotland: increased risk or increased detection?  BJU Int 2000; 85: 463-472.

Brewster DH, Stockton DL, Harvey J, Mackay M. Reliability of cancer registration data in Scotland, 1997. Eur J Cancer 2002; 38: 414-417.

Ferlay J, Bray F, Pisani P, Parkin DM.Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. Lyon: IARCPress, 2004. Lyon: IARCPress, 2004. (The GLOBOCAN database is an electronic version of this).

Forman D, Stockton D, Moller H, Quinn M, Babb P, De Angelis R, Micheli A. Cancer Prevalence in the UK: results from the EUROPREVAL Study. Annals of Oncol 2003; 14: 648-654.

Howard GCW, Thomson CS, Stroner PL, Goodman CM, Windsor PM, Brewster DH.  Patterns of referral, management and survival of patients diagnosed with prostate cancer in Scotland during 1988 and 1993: results of a national, retrospective population-based audit.  BJU Int 2001; 87: 339-347.

Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R & the EUROPREVAL Working Group. Cancer prevalence in European registry areas. Annals of Oncology 2002; 13: 840865.

NHS Quality Improvement Scotland. Clinical Indicators 2005. Edinburgh: NHSQIS, 2005: pp 110-116.PDF Button

Scottish Executive Health Department. Cancer in Scotland: Action for Change, 2001. Edinburgh: Scottish Executive, 2001.

Sharpe K. Better Cancer Care: Better Cancer Care: An Aid to Planning Cancer Services. Cancer Incidence Projections for Scotpland (2006 - 2020) Updatedto reflect 2006-based Population Projections. Edinburgh: Scottish Government, 2008.

Scottish Executive Health Department. Cancer in Scotland: Sustaining Change, 2004. Edinburgh: Scottish Executive, 2004.

Scottish Government Health Directorate. Better Cancer Care, An Action Plan, 2008  Edinburgh: Scottish Government, 2008.

Stockton DL. Sustaining change: Cancer Incidence Projections for Scotland (2001 - 2020) - An Aid to Planning Cancer Services. Edinburgh: Scottish Executive, 2004.

Wood H, Cooper N, Rowan S, Quinn M. Prostate. In: Quinn M, Wood H, Cooper N, Rowan S (eds). Cancer Atlas of the United Kingdom and Ireland 1991-2000. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005. PDF Button

Effectiveness evidence

ScotPHO’s purpose is to describe the pattern of health across the Scottish population. As a supplementary service to users, we include the following links to external sources of quality-assured evidence on effectiveness of interventions which may include relevant material for this topic.

NHS Health Scotland: Scottish perspectives on NICE public health guidance - Index page

National Library for Public Health - Home page

Centre for Reviews and Dissemination - Home page

Cochrane Reviews - Topic index page

EPPI-Centre: Evidence library - Home page

National Institute for Health and Clinical Excellence (NICE) guidance - Topic index page

Scottish Intercollegiate Guidelines Network (SIGN) - Home page

Note: The effectiveness evidence links are provided as an aid to users. They are by no means exhaustive nor should they be necessarily viewed as authoritative. The usual ScotPHO disclaimer about links to external sites applies.